1. Babazade R, Turan A. Pharmacokinetic and pharmacodynamic evaluation of sublingual sufentanil in the treatment of post-operative pain. Expert Opinion on Drug Metabolism & Toxicology. 2016;12(2):217-224.
4. Van de Donk T, Ward S, Langford R, Dahan A. Pharmacokinetics and pharmacodynamics of sublingual sufentanil for postoperative pain management. Anaesthesia. 2017;73(2):231-237.
5. Food and Drugs Administration. Sufentanil Citrate Injection, USP CII [Internet]. Accessdata.fda.gov. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019050s032lbl.pdf
9. Sacerdote P, Coluzzi F, Fanelli A. Sublingual sufentanil, a new opportunity for the improvement of postoperative pain management in Italy. European Review for Medical and Pharmacological Sciences. 2016;20:1411-1422.
10. Maciejewski D. Sufentanil in anaesthesiology and intensive therapy. Anaesthesiology Intensive Therapy 2012; 44: 35-41
11. Minkowitz H. A review of sufentanil and the sufentanil sublingual tablet system for acute moderate to severe pain. Pain Management. 2015;5(4):237-250
12. Lundeberg S, Roelofse JA. Aspects of pharmacokinetics and pharmacodynamics of sufentanil in pediatric practice. Pediatric Anesthesia, 2010. 21(3): 274–279. doi:10.1111/j.1460-9592.2010.03411.x